U.S. FDA approves Amylyx ALS drug | Reuters

U.S. FDA approves Amylyx ALS drug | Reuters: The U.S. Food and Drug Administration on Thursday approved Amylyx Pharmaceuticals Inc's drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death.

Comments

Popular posts from this blog

Charles Spurgeon's "Faith's Checkbook" Devotional for January 1

Wayside Chapel Daily Devotional 1st January 2026